Business Description
This fund focuses on companies around the world that are positioned to profit from the growing weight loss drug market, including pharmaceutical makers, telehealth providers, and developers of related combination treatments. At least 80% of its assets are invested in stocks that mirror a specialized index tracking this space. The fund holds a concentrated portfolio and is not diversified across broader market sectors.
